Sharman JP, Munir T, Grosicki S, Roeker LE, et al. Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321). J Clin Oncol 2025 Jul 29:JCO2501700. doi: 10.1200/JCO-25-01700.
PMID: 40729625